Weekly gemcitabine as a radiosensitiser for the treatment of brain metastases in patients with non-small cell lung cancer: phase I trial.

Huang, Yu-juan

Weekly gemcitabine as a radiosensitiser for the treatment of brain metastases in patients with non-small cell lung cancer: phase I trial. [electronic resource] - Chinese medical journal Mar 2007 - 458-62 p. digital

Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't

0366-6999


Aged
Brain Neoplasms--radiotherapy
Carcinoma, Non-Small-Cell Lung--pathology
Cranial Irradiation
Deoxycytidine--administration & dosage
Female
Humans
Lung Neoplasms--pathology
Male
Maximum Tolerated Dose
Middle Aged
Radiation-Sensitizing Agents--administration & dosage
Gemcitabine